GLP-1s Versus DPP-4s and Risk of Dementia in Patients Requiring Hemodialysis: A Target Trial Emulation Study
In patients with diabetes requiring hemodialysis, GLP-1s (vs. DPP-4s) may be a promising therapy to reduce the risk of dementia.
Authors
- Morgan E. Grams (ORCID: https://orcid.org/0000-0002-4430-6023)
- Walter K. Kraft (ORCID: https://orcid.org/0000-0002-5074-0141)
- Jung‐Im Shin (ORCID: https://orcid.org/0000-0003-0374-6927)
- Bernard G. Jaar (ORCID: https://orcid.org/0000-0003-1210-7115)
- Dustin Le (ORCID: https://orcid.org/0000-0003-3231-6758)
- Michael E. Kilpatrick
Institutions
- Johns Hopkins University (US)
- Thomas Jefferson University (US)
- Johns Hopkins Medicine (US)
- Precision for Medicine (United States) (US)
Publication Details
- Journal
- Diabetes Care
- Published
- 2025-11-13
- DOI
- https://doi.org/10.2337/dc25-1836
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00